Results 71 to 80 of about 6,391 (215)

Population balance modeling and digital design of degree of agglomeration in industrial crystallization

open access: yesAIChE Journal, Volume 72, Issue 10, October 2026.
Abstract This study presents a coupled population balance model (PBM) for describing the degree‐of‐agglomeration (DoA) in crystallization by independently tracking total particle and agglomerate number densities. Applied to an industrial active pharmaceutical ingredient, the model outperformed bridge‐counting methods and accurately captured DoA trends ...
Yung‐Shun Kang   +6 more
wiley   +1 more source

Pharmaceutical manufacturing and the quality by design (QBD), process analytical technology (PAT) approach [PDF]

open access: yes, 2016
This paper is the result of a literature review focusing on the application of process analytical technology (PAT) for the pharmaceutical industry in conjunction with the quality by design (QBD) framework. PAT and the QBD framework put forward by the FDA,
Trevor Murphy   +5 more
core   +1 more source

Beyond Blind Trust in Hospital Data Warehouses: Evaluating Real‐World Data Accountability

open access: yesLearning Health Systems, Volume 10, Issue 4, October 2026.
ABSTRACT Introduction The reliability of real‐world evidence (RWE) depends on data accuracy and secondary users' ability to evaluate how data are generated and transformed. Although recent frameworks emphasize provenance, transparency, and auditability, their practical assessment in routine hospital settings remains unclear.
Akemi Morohashi   +6 more
wiley   +1 more source

Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications

open access: yesPharmaceutics
Background/Objectives: Quality by Design (QbD) has revolutionized pharmaceutical development by transitioning from reactive quality testing to proactive, science-driven methodologies.
Shiwei Yang   +8 more
doaj   +1 more source

Receptor‐Targeted Niosomal Nanocarriers: Advances, Challenges, and Opportunities in Natural Compound Delivery for Cancer Therapy

open access: yesNano Select, Volume 7, Issue 10, October 2026.
Surface‐modified niosomes are introduced as multifunctional nanoparticles for precision tumor treatment that combine hydrophilic and lipophilic drug encapsulation with ligand‐based targeting via antibodies, peptides, transferrin, and folic acid. This modification leads to increased tumor selectivity, facilitates cell entry, and enables enhanced ...
Narges Sahraei   +3 more
wiley   +1 more source

The statutory ground to award security for costs against an impecunious company: should we mourn its passing? [PDF]

open access: yes, 2009
Analyses the approach of the courts to their jurisdiction to make an order for security for costs against an impecunious company under the Companies Act 1985 s.726 and under the CPR r.25.13(2)(c).
Ching, J
core  

Gonolobus in the spotlight: History, diversity, and citizen science

open access: yesTAXON, Volume 75, Issue 5, October 2026.
Abstract Gonolobus (Apocynaceae) is a distinctive genus of climbing plants, distributed from the southern United States to Argentina. This study presents a comprehensive, integrative analysis of the genus, synthesizing its intricate taxonomic history, biogeographic patterns, and the contribution of citizen science to its modern systematics. We compiled
Leonardo O. Alvarado‐Cárdenas   +4 more
wiley   +1 more source

Cellularized Skin Substitute Bioengineering for Regenerative Medicine: Cell Sources, Culture Strategies, and Transition Toward Defined, Xeno‐Free Culture Systems

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 34, 11 September 2026.
Advances in cell sources, bioengineering, and manufacturing are reshaping the design of skin substitutes. This review highlights emerging strategies driving skin tissue engineering and discusses their potential to enable safer, reproducible, and clinically accessible skin substitutes for regenerative medicine.
Gilles Lemaître   +7 more
wiley   +1 more source

Analysis and critical review of ICH Q8, Q9 and Q10 from a generic pharmaceutical industry view point [PDF]

open access: yesMakedonsko Farmacevtski Bilten, 2012
Generic industry aims to produce safe, efficient, built-in quality medicines that will satisfy patients’ requirements and will be competitive on the market.
Ljuba Karanakov   +3 more
doaj  

Magnetically Driven Biofabrication for Tissue Engineering: From Nanoparticle Design to Mag‐ATMP Translation

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 36, 25 September 2026.
Magnetically responsive nanoparticles enable remote control over biomaterials, cells, and engineered tissues. This review summarizes material design, biological safety, fabrication and actuation strategies, computational validation, and translational pathways that support the development of magnetic tissue‐engineering platforms and future magnetically ...
Konstantinos Ioannidis   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy